BJDX · Bluejay Diagnostics, Inc. · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“These financial results and financial position, and the Company’s expected forward-looking outlook of significant negative cash flow in the future, raise substantial doubt with respect to its ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-17 | ZEIDMAN FRED S |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents out-of-the-money stock options that vest and become exercisable for $2.075 per share on the first anniversary of the grant date, provided, however, that the options shall not be exercisable unless and until the U.S. Food and Drug Administration shall have granted clearance or approval of the issuer's Symphony IL-6 point-of-care testing device. |
Stock Option (Right to Buy)
|
100,000 |
| 2026-08-17 | Dey Indranil |
Director, President and CEO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
These shares represent restricted stock units granted by the board of directors of the issuer. |
Common Stock
|
28,000 |
| 2026-08-17 | Wurth Douglas Clark |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents out-of-the-money stock options that vest and become exercisable for $2.075 per share on the first anniversary of the grant date, provided, however, that the options shall not be exercisable unless and until the U.S. Food and Drug Administration shall have granted clearance or approval of the issuer's Symphony IL-6 point-of-care testing device. |
Stock Option (Right to Buy)
|
100,000 |
| 2026-08-17 | Dey Svetlana |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents out-of-the-money stock options that vest and become exercisable for $2.075 per share on the first anniversary of the grant date, provided, however, that the options shall not be exercisable unless and until the U.S. Food and Drug Administration shall have granted clearance or approval of the issuer's Symphony IL-6 point-of-care testing device. |
Stock Option (Right to Buy)
|
100,000 |
| 2026-08-17 | CHASE DONALD R |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Represents out-of-the-money stock options that vest and become exercisable for $2.075 per share on the first anniversary of the grant date, provided, however, that the options shall not be exercisable unless and until the U.S. Food and Drug Administration shall have granted clearance or approval of the issuer's Symphony IL-6 point-of-care testing device. |
Stock Option (Right to Buy)
|
100,000 |
| 2026-07-10 | HRT FINANCIAL LP |
10% Owner |
Sell↓
|
Common Stock
|
34,938 |
| 2026-07-09 | HRT FINANCIAL LP |
10% Owner |
Buy↑
|
Common Stock
|
64,047 |
| 2026-03-14 | Dey Indranil |
Director, President and CEO, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
On March 14, 2026, Mr. Dey purchased 12,500 shares of the issuer's common stock from the issuer in a private placement at a price of $2.00 per share. |
Common Stock
|
12,500 |
| 2026-03-14 | CHASE DONALD R |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
On March 14, 2026, Mr. Chase purchased 12,500 shares of the issuer's common stock from the issuer in a private placement at a price of $2.00 per share. |
Common Stock
|
12,500 |
| 2026-03-14 | ZEIDMAN FRED S |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
On March 14, 2026, Mr. Zeidman purchased 12,500 shares of the issuer's common stock from the issuer in a private placement at a price of $2.00 per share. |
Common Stock
|
12,500 |
| 2026-03-14 | Wurth Douglas Clark |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
On March 14, 2026, Mr. Wurth purchased 12,500 shares of the issuer's common stock ("Common Stock") from the issuer in a private placement at a price of $2.00 per share. Of such amount, 34 shares of Common Stock are held by Wurth Holdings LLC, an entity controlled by Mr. Wurth. |
Common Stock
|
12,500 |
| 2026-03-14 | Dey Svetlana |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
On March 14, 2026, Ms. Dey purchased 12,500 shares of the issuer's common stock from the issuer in a private placement at a price of $2.00 per share. |
Common Stock
|
12,500 |
| 2023-12-13 | Dey Svetlana |
Director |
Buy↑
|
Common Stock
|
500 |
| 2023-12-13 | Dey Indranil |
Director, President and CEO, 10% Owner |
Buy↑
|
Common Stock
|
500 |
| 2023-03-28 | Dey Indranil |
Director, President and CEO, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
The original Form 4, filed on March 28, 2023 is being amended by this Form 4 amendment solely to correct an administrative error which misreported this transaction as a grant with a transaction code of "A" instead of an open market purchase with a transaction code of "P." |
Common Stock
|
2,000 |
| 2023-03-27 | Dey Indranil |
Director, President and CEO, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
The original Form 4, filed on March 28, 2023 is being amended by this Form 4 amendment solely to correct an administrative error which misreported this transaction as a grant with a transaction code of "A" instead of an open market purchase with a transaction code of "P." |
Common Stock
|
8,000 |
| 2023-03-24 | Dey Svetlana |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
The original Form 4, filed on March 24, 2023 is being amended by this Form 4 amendment solely to correct an administrative error which misreported this transaction as a grant with a transaction code of "A" instead of an open market purchase with a transaction code of "P." |
Common Stock
|
10,000 |
| 2023-02-01 | ZEIDMAN FRED S |
Director |
Award↑
|
Common Stock
|
27,500 |
| 2023-02-01 | CHASE DONALD R |
Director |
Award↑
|
Common Stock
|
27,500 |
| 2023-02-01 | Gemignani Gary G |
Director |
Award↑
|
Common Stock
|
27,500 |
| 2023-02-01 | Dey Svetlana |
Director |
Award↑
|
Common Stock
|
27,500 |
| 2023-02-01 | Fisher Kenneth R |
Chief Financial Officer |
Tax↓
|
Common Stock
|
39,316 |
| 2023-02-01 | Fisher Kenneth R |
Chief Financial Officer |
Award↑
|
Common Stock
|
112,500 |
| 2023-02-01 | Dey Indranil |
Director, President and CEO, 10% Owner |
Tax↓
|
Common Stock
|
55,612 |
| 2023-02-01 | Wurth Douglas Clark |
Director |
Award↑
|
Common Stock
|
27,500 |
| 2023-02-01 | Dey Indranil |
Director, President and CEO, 10% Owner |
Award↑
|
Common Stock
|
159,090 |
| 2022-08-26 | Fisher Kenneth R |
Chief Financial Officer |
Buy↑
|
Common Stock
|
20,000 |
| 2022-04-25 | Fisher Kenneth R |
Chief Financial Officer |
Buy↑
|
Common Stock
|
20,000 |
| 2022-03-23 | Fisher Kenneth R |
Chief Financial Officer |
Award↑
Filing footnotes — Option (right to buy) (Direct)
Issued in connection with the reporting person's employment with the Company. Of the option grant, 5,000 shares were fully-vested on the Transaction Date and 60,000 shares will vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. |
Option (right to buy)
|
65,000 |
| 2022-03-22 | Gemignani Gary G |
Director |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's Board of Director services to the Company. The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date. |
Option to purchase common stock
|
2,500 |
| 2022-03-22 | CHASE DONALD R |
Director |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's Board of Director services to the Company. The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date. |
Option to purchase common stock
|
2,500 |
| 2022-03-22 | Dey Svetlana |
Director |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's Board of Director services to the Company. The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date. |
Option to purchase common stock
|
2,500 |
| 2022-03-22 | Wurth Douglas Clark |
Director |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's Board of Director services to the Company. The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date. Includes warrants to purchase 69,868 shares of common stock held indirectly by Wurth Holdings, LLC and options to purchase 157,360 shares of common stock held directly by the reporting person. |
Option to purchase common stock
|
2,500 |
| 2022-03-22 | ZEIDMAN FRED S |
Director |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's Board of Director services to the Company. The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date. |
Option to purchase common stock
|
2,500 |
| 2022-03-17 | Wurth Douglas Clark |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $1.15 to $1.20. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Does not include 1,108,883 shares held indirectly by Wurth Holdings, LLC. |
Common Stock
|
40,000 |
| 2022-03-17 | Dey Svetlana |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $1.17 to $1.19. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Does not include 4,091,356 shares held by Lana Management & Business Research International, LLC, an entity owned by Mr. Indranil Dey and Ms. Svetlana Dey. Ms. Dey has voting and dispositive power over the shares held by such entity. |
Common Stock
|
10,000 |
| 2022-03-17 | Kinder Gordon Winston |
Chief Financial Officer |
Buy↑
|
Common Stock
|
2,500 |
| 2022-03-16 | Kinder Gordon Winston |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $1.01 to $1.04. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
5,000 |
| 2022-03-16 | Wurth Douglas Clark |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $1.01 to $1.15. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Does not include 1,108,883 shares held indirectly by Wurth Holdings, LLC. |
Common Stock
|
60,000 |
| 2022-03-15 | Kinder Gordon Winston |
Chief Financial Officer |
Buy↑
|
Common Stock
|
500 |
| 2022-03-14 | Kinder Gordon Winston |
Chief Financial Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $0.90 to $0.95. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
10,500 |
| 2022-02-25 | Kinder Gordon Winston |
Chief Financial Officer |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's employment services to the Company pursuant to the employment agreement between the reporting person and the Company dated July 1, 2021. The stock options set forth in this table vest in three equal annual installments, subject to the grantee's continued service to the Company on each vesting date. |
Option to purchase common stock
|
8,066 |
| 2022-02-25 | Dey Indranil |
Director, President and CEO, 10% Owner |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's employment services to the Company pursuant to the employment agreement between the reporting person and the Company dated July 1, 2021. The stock options set forth in this table vest in three equal annual installments, subject to the grantee's continued service to the Company on each vesting date. |
Option to purchase common stock
|
14,116 |
| 2022-01-10 | Dey Svetlana |
Director |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's Board of Director services to the Company. The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date. |
Option to purchase common stock
|
25,000 |
| 2022-01-10 | ZEIDMAN FRED S |
Director |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's Board of Director services to the Company. The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date. |
Option to purchase common stock
|
15,000 |
| 2022-01-10 | CHASE DONALD R |
Director |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's Board of Director services to the Company. The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date. |
Option to purchase common stock
|
25,000 |
| 2022-01-10 | Wurth Douglas Clark |
Director |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's Board of Director services to the Company. The stock options set forth in this table vest on December 15, 2022, subject to the grantee's continued service to the Company on the vesting date. Includes warrants to purchase 69,868 shares of common stock held indirectly by Wurth Holdings, LLC and options to purchase 157,360 shares of common stock held directly by the reporting person. |
Option to purchase common stock
|
25,000 |
| 2021-12-15 | Gemignani Gary G |
Director |
Award↑
Filing footnotes — Option to purchase common stock (Direct)
The stock options were issued in connection with the reporting person's Board of Director services to the Company. The stock options set forth in this table vest on the one-year anniversary of the date hereof, subject to the grantee's continued service to the Company on the vesting date. |
Option to purchase common stock
|
25,000 |